Anti-anginal and anti-thrombotic drugs Flashcards
4 anti-platelets?
clopidogrel (plavix)
ticagrelor
prasugrel
aspirin
MOA: irreversibly blocks P2Y component of ADP receptors on platelet surface, prevents activation of GPIIb/IIIa receptor complex & reduces platelet aggregation
clopidogrel, an anti-platelet
distinguishing characteristics: Metabolized extensively hepatic via esterase-mediated hydrolysis to a carboxylic acid derivative (inactive) and via CYP450-mediated (CYP2C19, primarily) oxidation to a thiol metabolite (active)
predicted actions: onset is detected by 2nd day of tx, duration lasts for lifespan of platelet
uses: post NSTEMI, ACS, CVA, PCI, arterial occlusive dz to prevent clots
SEs: similar bleeding risk compared to aspirin, slight advantage w/GI bleeds
clopidogrel, an anti-platelet
2 NO activating drugs? category?
nitroglycerine
isosorbide mononitrate
both nitrates
MOA: relaxation of vascular MS & vasodilation
nitrates: nitroglycerine, isosorbide mononitrate
distinguishing characteristics: various forms that change duration and onset, extensive 1st pass metabolism
predicted actions: Onset is 1-3min, 30min (patch), or 60min; duration 25min, 4-8hrs, or 10-12hrs; venous dilation leads to a reduced arterial pressure, reduced preload, reduced oxygen consumption; prefers coronary vessels over peripheral vessels
uses: angina (prophylactic & acute)
SEs: hypotension, H/A, flushing, light-headedness
avoid PDE-5 inhibitors
nitroglycerin
distinguishing characteristics: onset is 30-45 mins, lasts >6 hrs, extensive 1st pass metabolism
uses: angina pectoris
SEs: hypotension, flushing, light-headedness
isosorbide mononitrate
3 beta blockers?
part of class II drugs
metoprolol
atenolol
propranolol
MOA: B1 receptor antagonist
distinguishing characteristics: cardioselective, metabolized through CYP2D6 & 2C19
predicted actions: onset 1 hours, duration 3-6 hrs or 24 hrs in ER form, blunts cardiac stimulation, prevents reflex tachycardia, decreased HR, contractility & BP
uses: MI, CHF, angina, THN
SEs: bradycardia, heart block, H/A, fatigue, eercise intolerance, hypotension, erectile dysfxn
no risk to diabetic or asthmatic pts
metoprolol
MOA: B1 receptor antagonist
distinguishing characteristics: limited hepatic metabolism, higher mortality concern unless used w/a silent ischemia then better outcomes
predicted actions: onset <1 hr, duration 12-24 hrs
uses: MI, HTN, angina
SEs: bradycardia, heart block H/A, fatigue, exercise intolerance, hypotension, erectile dysfxn
don’t drink apple juice with!!
atenolol
MOA: B1 & B2 receptor antagonist
distinguishing characteristics: very lipid soluble, significant 1st pass metabolism, highly variable plasma levels, metabolized through CYP1A2, 2C19, 2D6, 3A4, inhibits 1A2 & PgP
predicted actions: onset is 12 hrs, duration 6-12 or 24-27 hrs
uses: MI (tx & prevention), HTN, angina, migraine prophylaxis, SV arrhythmias
SEs: bradycardia, heart block, H/A, fatigue, exercise intolerance, hypotension, erectile dysfxn, C/I in diabetic & asthmatic pts
propranolol
MOA: non-selective A1 adrenergic blockade
carvedilol class II drug
distinguishing characteristics: Metabolized through CYP1A4, 2C9, 2D6, 2E1, 3A4; inhibits PgP
predicted actions: onset <1 hr, duration 24 hrs
uses: MI, HTN, CHF, angina
avoid grapefruit juice since increases bioavailability
carvedilol
3 CCBs?
amlodipine (dihydropyridine)
verapamil (diphenyl alkamine)
diltiazem (benzothiazepine)
MOA: blocks Ca2+ influx leading to relaxation of SM, has more effect on peripheral tissues
amlodipine